Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...

A clinical trial involves the study of the safety, efficacy and/or dosage regimen of a therapeutic intervention (such as a drug) in humans selected according to predetermined criteria of ...

Swedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals with acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS). This ...

Replacing transplant and chemo with CI-based therapy and ISRT maintains survival, reduces side effects in younger patients ...

In the recently published Heart Outcomes Prevention Evaluation (HOPE) study, treatment with the ACE inhibitor ramipril reduced cardiovascular mortality and morbidity in a broad range of patients at ...

The proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit. HealthDay News — One in 6 patients in phase 2 clinical cancer trials ...

Wirostko also uses the device in her practice and has performed clinical research on its efficacy with colleagues at Moran and the Wilmer Eye Institute at Johns Hopkins University School of Medicine. ...

WEDNESDAY, Feb. 26, 2025 (HealthDay News) -- One in six patients in phase 2 clinical cancer trials receives treatments that are eventually approved, according to a study published online Feb. 25 in ...

Clinical trial matchmaker myTomorrows has struck up a partnership with personal health recordkeeper Patients Know Best (PKB) so that U.K. participants can search for possible trials to join.

This course is a practical, interactive workshop for those working in clinical trials who already or wish to actively involve patients or the public in their trials. It offers participants the ...

LibreClinica is the community driven successor of OpenClinica. It is an open source clinical trial software for Electronic Data Capture (EDC) Clinical Data Management (CDM).

CereVasc today announced the first patient randomized to and treated with the eShunt system in its STRIDE clinical trial. STRIDE, a head-to-head comparison, pits the novel eShunt system against ...